The Food and Drug Administration (FDA) temporarily suspended on Tuesday its ban on sales of the popular e-cigarette maker Juul, the agency’s tobacco division wrote in a tweet.
After establishing the existence of scientific issues unique to the JUUL application that require additional review, the agency administratively stayed the marketing denial order during the additional review, stressing, however, that this does not rescind the order.
FDA Tobacco noted that all ENDS (electronic nicotine delivery systems) products are required by law to obtain FDA authorization to be legally marketed, concluding that the stay and the additional review do not constitute authorization to market, sell, or ship JUUL products.
So, for the time being, the company is allowed to market its products in the US, the agency said.
FDA banned the sale of Juul e-cigarettes in mid-June, emphasizing that its producer failed to prove that keeping its e-cigarettes on the market is appropriate for the protection of public health.
FDA Commissioner Robert Califf also noted that the JUUL’s producer has significantly increased vaping among US youth, stressing that the agency is committed to ensuring that all e-cigarettes and ENDS currently marketed to consumers meet its public health standards
The FDA ban on JUUL was temporarily blocked a day later by a federal appeals court which accepted the e-cigarette maker’s request for a stay, giving it a reprieve while the court hears more arguments.
After being first introduced on the market as a healthier alternative to smoking traditional tobacco cigarettes, e-cigarettes have been the most commonly used tobacco product among US youth since 2014.
Responding to the growing pressure to regulate vaping by worrying parents and health experts, the FDA initiated a broad review of the vaping industry to decide which products to allow on the market.
Be the first to comment